A study based on a nationally representative sample of adults in China in 2010 indicates that nearly 12 percent of Chinese adults had diabetes and the prevalence of prediabetes was about 50 percent, according to a study in ...
Sep 3, 2013
0
0
(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.
Dec 26, 2017
0
6
Type 2 diabetes (T2D) accounts for more than 90% of the confirmed diabetes cases. It has become a common metabolic disease and is expected to affect 380 million people worldwide by 2025. Currently, clinically used diagnostic ...
Mar 10, 2023
0
5
(HealthDay)—Mini-dose glucagon (MDG) is an effective approach for preventing exercise-induced hypoglycemia in patients with type 1 diabetes, according to a study published online May 18 in Diabetes Care.
May 30, 2018
0
1
People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.
Jul 18, 2023
0
16
(Medical Xpress) -- A new Iowa State University study confirms your mom was right, you should chew your food thoroughly. Mom's logic was that proper chewing would ease digestion, but the ISU research found that chewing food ...
Apr 18, 2012
0
0
Ever since the appetite-regulation hormone called leptin was discovered in 1994, scientists have sought to understand the mechanisms that control its action. It was known that leptin was made by fat cells, reduced appetite ...
Apr 17, 2013
0
0
Researchers used continuous glucose monitoring (CGM) to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes (T2D) and found significant reductions in mean ...
Oct 1, 2018
1
1
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared ...
Aug 27, 2012
0
0
(HealthDay)—The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus (T2DM), according to a study published online Oct. 19 in JCI Insight.
Nov 20, 2017
0
0
